Current Trends • 2025–2026

Value Analysis Committees
How Medical Device Sales Has Changed

VACs influence (or control) many purchasing decisions. This guide breaks down what VACs care about, how reps can succeed, and what employers should screen for.

Key takeaways

More stakeholders, less preference selling

VACs require you to influence clinical, supply chain, and finance—not just one champion.

ROI and evidence matter more

Outcomes, utilization, and cost impact are central to approvals.

Sales cycles are more formal

Expect documentation, trials, and structured evaluations.

Employers hire for committee readiness

VAC fluency is becoming a core hiring requirement for many device roles.

What is a Value Analysis Committee?

A Value Analysis Committee (VAC) is a cross-functional group that evaluates products based on clinical value, cost, operational impact, and outcomes—often across multiple facilities within a system.

  • Clinical leadership (service line leaders, nursing leadership, physicians)
  • Supply chain & procurement (standardization, vendor contracts, sourcing)
  • Finance & administration (budget impact, total cost, reimbursement considerations)
  • Quality & risk management (safety, outcomes, compliance, policy alignment)

Why VACs matter more than ever

With tighter budgets and system-level oversight, hospitals can’t rely solely on clinician preference. Purchases are justified across multiple dimensions: outcomes, efficiency, utilization, and cost.

  • Standardization across multiple facilities (system-wide contracts)
  • Reduced vendor redundancy and SKU simplification
  • Stronger price controls and comparative evaluation
  • Greater accountability for outcomes and operational impact

How medical device sales has changed

Selling to one champion is rarely enough. Reps increasingly win by building a stakeholder map, aligning outcomes with financial impact, and supporting structured evaluations.

  • More formal presentations and documentation (clinical + financial)
  • Longer evaluation timelines (trials, committees, approvals)
  • Greater emphasis on evidence and real-world results
  • Less tolerance for “nice-to-have” products without measurable impact

What reps need to succeed with VACs

High-performing reps treat VACs as a process—not an obstacle. The goal is to translate product value into outcomes and operational wins that multiple stakeholders can support.

  • Understand cost structures: where savings show up (labor, utilization, complications, waste)
  • Bring a clear ROI narrative with realistic assumptions (not hype)
  • Align benefits to outcomes: efficiency, safety, standardization, throughput
  • Coach champions: who needs to approve, what objections to expect, what data to provide

What employers look for now

Many companies screen for reps who can navigate VACs with confidence—because committee-driven purchasing is now the default in many systems.

  • Clear examples of winning committee-driven deals (not just relationships)
  • Strong communication and presentation skills across clinical + admin audiences
  • Ability to manage multi-stakeholder processes and longer cycles
  • Comfort with value messaging: outcomes, economics, and operational impact

How MedSales Network helps

Candidates can highlight VAC experience, deal stories, and operational impact. Employers can filter and identify talent with the skills needed to win in committee-driven buying environments.

Match on committee readiness

Reduce noise and connect faster with profiles built for today’s buying process.